Relay Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Relay Therapeutics, Inc. (RLAY) had Common Stock, Capital Shares Reserved for Future Issuance of 8.03 million shares as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes › Equity › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2021-03-25
- 2020-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.03M shares.
- 2019-12-31: Common Stock, Capital Shares Reserved for Future Issuance 68.29M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2020-12-31 | 8.03M shares 10-K · filed 2021-03-25 |
| 2019-12-31 | 68.29M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |